Nonpharmacological treatment of hypercholesterolemia increases circulating endothelial progenitor cell population in adults [1]

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 5, 2006, Pages

  Croce, Giuseppe ^a   Passacquale, Gabriella ^a   Necozione, Stefane ^a   Ferri, Claudio ^a   Desideri, Giovambattista ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; ENDOTHELIUM CELL; EXERCISE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; LOW FAT DIET; MALE; PRIORITY JOURNAL; STEM CELL; VASCULAR ENDOTHELIUM; BLOOD; CELL COUNT; DIET; HEMATOPOIETIC STEM CELL; PHYSIOLOGY;

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; CELL COUNT; CHOLESTEROL, LDL; DIET; ENDOTHELIAL CELLS; EXERCISE; HEMATOPOIETIC STEM CELLS; HUMANS; HYPERCHOLESTEROLEMIA;

EID: 33646441907     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000218504.71680.b5     Document Type: Letter

References (11)

1. Desideri G, Ferri C. Endothelial activation. Sliding door to atherosclerosis. Curr Pharm Des. 2005;11:2163-2175.
2. Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH, Zhu JH. Number and activity of endothelial progenitor cells from pheripheral blood in patients with hypercholesterolaemia. Clin Sci. 2004;107:273-280.
3. Urbich C, Dimmeler S. Endothelial progenitor cells. Characterization and vascular biology. Circ Res. 2004;95:343-353.
4. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Eng J Med. 2005;353:999-1007.
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106:3143-3421.
6. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Pina IL, Rodney R, Simons-Morton DA, Williams MA, Bazzarre T. Exercise standards for testing and training. A statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:1694-1740.
7. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97:3422-3427.
8. Imanishi T, Hano T, Matsuo Y, Nishio I. Oxidized low-density lipoprotein inhibits vascular endothelial growth factor-induced endothelial progenitor cell differentiation. Clin Exp Pharmacol Physiol 2003;30:665-670.
9. Imanishi T, Hano T, Sawamura T, Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol. 2004;31:407-413.
10. Davì G, Alessandrini P, Mezzetti A, Minotti G, Bucciarelli T, Costantini F, Cipollone F, Bon GB, Ciabattoni G, Patrono C. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1997;17:3230-3235.
11. Desideri G, Croce G, Tucci M, Passacquale G, Broccoletti S, Valeri L, Santucci A, Ferri C. Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments. J Clin Endocrinol Metab. 2003;88:5341-5347.